Homozygous Tangier disease and cardiovascular disease.

@article{SerfatyLacrosnire1994HomozygousTD,
  title={Homozygous Tangier disease and cardiovascular disease.},
  author={C Serfaty-Lacrosni{\`e}re and Fernando Civeira and A Lanzberg and P Isaia and J{\"o}rg Berg and Edward Janus and Mark Philip Smith and Peter C. H. Pritchard and Jiri Frohlich and Robert S. Lees},
  journal={Atherosclerosis},
  year={1994},
  volume={107 1},
  pages={85-98}
}
Decreased levels of plasma high density lipoprotein (HDL) cholesterol have been associated with premature cardiovascular disease (CVD). Tangier disease is an autosomal co-dominant disorder in which homozygotes have a marked deficiency of HDL cholesterol and apolipoprotein (apo) A-I levels (both < 10 mg/dl), decreased low density lipoprotein (LDL) cholesterol levels (about 40% of normal), and mild hypertriglyceridemia. Homozygotes develop cholesterol ester deposition in tonsils (orange tonsils… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 70 extracted citations

ATP-binding cassette transporter A1 and HDL metabolism: effects of fatty acids.

The Journal of nutritional biochemistry • 2012
View 4 Excerpts
Highly Influenced

Familial Dyslipidaemias

View 11 Excerpts
Highly Influenced

Accelerated Atherogenicity in Tangier Disease

Journal of atherosclerosis and thrombosis • 2018

The Eye in Pediatric Systemic Disease

Springer International Publishing • 2017
View 2 Excerpts

Implications of reverse cholesterol transport: recent studies.

Clinica chimica acta; international journal of clinical chemistry • 2015
View 1 Excerpt

Similar Papers

Loading similar papers…